Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Havn Life Sciences Inc
(CSE:
HAVN
)
0.0300
UNCHANGED
Last Price
Updated: 2:12 PM EST, Nov 9, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.0300
Bid (Size)
0.0200 (1,000)
Ask (Size)
0.0300 (197,000)
Prev. Close
0.0300
Today's Range
0.0300 - 0.0300
52wk Range
0.0150 - 0.0450
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Power Play by The Market Herald Releases New Interviews with SuperBuzz, HAVN Life Sciences and RevoluGROUP Discussing Their Latest News
October 31, 2022
Via
ACCESSWIRE
HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
April 30, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
HAVN Life Sciences Inc.
Via
AccessWire
Performance
YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+50.00%
+50.00%
1 Year
-25.00%
-25.00%
More News
Read More
HAVN Life Sciences (CSE: HAVN) (OTC: HAVLF) Featured in Coverage of Planet MicroCap’s Virtual Investor Conference
April 14, 2022
Via
Investor Brand Network
Topics
Economy
Exposures
Supply Chain
HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) Featured in Virtual Coverage of LD Micro’s Main Event
October 01, 2021
Via
Investor Brand Network
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
December 06, 2021
From
Stock News Now
Via
AccessWire
HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
September 23, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Exposures
Product Safety
HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness
September 21, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Supply Chain
Exposures
Supply Chain
HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies
August 25, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility
August 03, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
HAVN Life Natural Health Products Now Available on Amazon.ca
July 29, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Signs Agreement to Enable Export of Psilocybin into Canada, the US and Europe
July 27, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Signs Exclusive Supply Agreement With Cube Psytech
July 08, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Sciences Signs Finished Goods Supply Agreement with Allied Health
June 29, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
HAVN Life Announces Retail Partnership with Grocer, Choices Markets
June 08, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Launches New Line of Natural Health Products
June 03, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug
June 02, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings
May 19, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
The Miracle Compound Tackling A Trillion Dollar Crisis
May 17, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches
May 17, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Havn Life CEO Tim Moore to Appear at Upcoming Q2 Investor SummitHavn Life CEO Tim Moore to Appear at Upcoming Q2 Investor Summit
May 14, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Havn Life Signs Exclusive Supply Agreement with ATMA Journey Centers
May 13, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Supply Chain
Exposures
Supply Chain
Havn Life Develops New Method for Rapid Psilocybin Testing
May 11, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Havn Labs Jamaica Facility Now Fully Operational
May 04, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027
April 14, 2021
Via
FinancialNewsMedia
Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021
April 19, 2021
From
Stock News Now
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.